Bibliography | 1.Tramonti A, Nardella C, di Salvo ML, Barile A, Cutruzzolà F, Contestabile R. Human Cytosolic and Mitochondrial Serine Hydroxymethyltransferase Isoforms in Comparison: Full Kinetic Characterization and Substrate Inhibition Properties. Biochemistry. 2018 Dec 26;57(51):6984-6996. doi: 10.1021/acs.biochem.8b01074. Epub 2018 Dec 7. PMID: 30500180. 2. C.C. Woo, W.C. Chen, X.Q. Teo, G.K. Radda, P.T. Lee, Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma, Oncotarget 7 (33) (2016) 53005–53017, http://dx.doi.org/10.18632/oncotarget.10415. 3.M. Marani, A. Paone, A. Fiascarelli, A. Macone, M. Gargano, S. Rinaldo, G.Giardina, V. Pontecorvi, D. Koes, L. McDermott, T. Yang, A. Paiardini, R.Contestabile, F. Cutruzzola, A pyrazolopyran derivative preferentially inhibitsnthe activity of human cytosolic serine hydroxymethyltransferase and induces cell death in lung cancer cells, Oncotarget 7 (4) (2016) 4570–4583, http://dx.doi.org/10.18632/oncotarget.6726 |